0001209191-17-048106.txt : 20170808 0001209191-17-048106.hdr.sgml : 20170808 20170808165422 ACCESSION NUMBER: 0001209191-17-048106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170804 FILED AS OF DATE: 20170808 DATE AS OF CHANGE: 20170808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NAZARIAN DANA CENTRAL INDEX KEY: 0001455837 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10079 FILM NUMBER: 171015489 MAIL ADDRESS: STREET 1: 198 CHAMPION COURT CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYPRESS SEMICONDUCTOR CORP /DE/ CENTRAL INDEX KEY: 0000791915 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 942885898 STATE OF INCORPORATION: DE FISCAL YEAR END: 0117 BUSINESS ADDRESS: STREET 1: 198 CHAMPION COURT CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 4089432600 MAIL ADDRESS: STREET 1: 198 CHAMPION COURT CITY: SAN JOSE STATE: CA ZIP: 95134 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-04 0 0000791915 CYPRESS SEMICONDUCTOR CORP /DE/ CY 0001455837 NAZARIAN DANA 198 CHAMPION COURT SAN JOSE CA 95134 0 1 0 0 EVP, Operations & Technology Common Stock 2017-08-04 4 S 0 250075 14.1036 D 302657 D Represents shares of Issuer common stock previously acquired by the Reporting Person upon vesting and settlement of restricted stock units and performance restricted stock units awarded to the Reporting Person under the Issuer's equity incentive plans. Restricted stock units and performance restricted stock units convert into common stock on a one-for-one basis upon vesting. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.205 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. /s/ Pamela Tondreau, attorney-in-fact 2017-08-08